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In the scientific world, the burden of proof for new claims is on the claimant. This is consistent
with probabilities, because most new suggestions do turn out to be false. There is no single path
from claim to proof This article illustrates four typical stages of the process, using the example
of a claim for effectiveness of a new treatment. They are labeled "Tentative or Suggestive
Evidence, " "Promising or Interesting, " "Probably Effective, " and "Established Effectiveness. 
"
Each is based on characteristic levels of evidence. A few clues for identifying naive enthusiasts
or outright frauds who try to shortcut these stages include claims of being ignored or rejected
by an "establishment" that is too self-interested or set in its ways to consider new approaches;
claims of special skills that others lack; vagueness about how the treatment has been evaluated
and tested; and expressions such as "amazing, " "unique, " "special, " and "never dreamed of. 
"
The world is full of claims of new and exciting things: from a better
mousetrap to an instant release for untapped inner powers-or a surefire cure
for anxiety. Each one brings with it the problem of deciding whether it is,
indeed, a great breakthrough, or just another dose of snake oil. There is no
single way of judging, but there are ways of minimizing mistakes at the
beginning, and of arriving at the truth in the end.
In the scientific world, a new claim is presumed false until proved
otherwise. In other words, the burden of proof is on the claimant. This is
consistent with the probabilities, because most new claims or ideas do in fact
turn out to be wrong. In science, as in other fields, there are standards of
evidence for each of the steps along the way from claim to proof. For the sake
of this discussion, let us take the case of a claim of effectiveness of a new
treatment.
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Tentative or Suggestive Evidence
At the beginning, the evidence usually consists of anecdotal observations,
single-case reports, or uncontrolled or open trials. An investigator can usually
get this sort of evidence published somewhere. Publishing in an independent,
scientific journal is the principal way an investigator submits his or her ideas
for review and criticism by others. Through these means, other investigators
are stimulated to try new ideas and to add their insights into the investigation.
To publish, the investigator must describe one or more cases, the new
treatment, and the therapeutic benefit, in a clear, objective way that does not
convey a sense of exaggeration or uncritical enthusiasm. He or she must also
show an awareness that only very tentative conclusions can be drawn from
such evidence.
A responsible investigator is expected to report the number of cases
studied and the study’s success ratio, as well as other factors that may have
influenced the outcome of the investigation. The argument for the treatment
is strengthened if there are several cases that have responded the same way;
if some, or all, were especially difficult cases for which the usually effective
treatments had failed; or if the impression of improvement is supported by
some type of objective measurement. At best, however, conclusions based on
this type of evidence are considered to be tentative or preliminary, warranting
further investigation, which may be done by the original investigator or his
or her peers. As additional trials are made, fragments of evidence accumulate.
Promising or Interesting
The next study stage is likely to be a prospective open trial, where cases
are selected so as to avoid stacking the deck for or against treatment. Cases
will be assessed/diagnosed by some method previously proved to be reliable
and accurate, and change will be measured by several different methods.
Normally some of these measures will be self-ratings or questionnaires filled
out by clients, and some will be ratings done by a specially trained clinical
investigator. Usually, the number of cases will not be large, and there will be
no placebo group (a harmless inactive treatment or drug) or other control
group.
If the results of several trials of this sort are fairly positive and consistent,
they may be considered promising or interesting. There may now be justifi-




The use of a control condition is crucial in treatment studies of mental
disorders because of the difficulty in assessing the cause of improvement.
The controlled study will include the features of the open trial plus a control
group or control condition. If it is a drug that is being evaluated, the control
may be a harmless sugar pill, a placebo, which looks exactly like the real
medicine. With psychosocial treatments, the control problem is more diffi-
cult. The investigator tries to think of some treatment that approximates the
one to be tested but that is known to have little or no effect.
The study should be designed so that about equally difficult cases get the
real treatment and the control treatment. The most effective way to do this is
to assign cases randomly to treatment or control conditions. Other ways are
the crossover design (where people alternate between a control and a trial
treatment) or the matched groups design (where each person in the test group
is paired with someone in the control group who is similar in age, sex,
severity, duration of illness, or other factors thought or known to influence
the outcome of treatment or course of illness).
Blindness is a strategy to minimize the very substantial effects that
expectations or beliefs can exert on the outcome as perceived by the client,
clinician, or observer. The person who assesses the degree of change should
be different from the clinician who provides the treatments. In tests of drug
treatments, by means of a placebo, both the therapist and the client can be
prevented from knowing whether the real or the control treatment is being
provided. In a study of psychosocial interventions, it is usually possible to
prevent only the person who assesses the change from knowing the client’s
assigned experimental group (real or placebo therapy).
It is relatively easy to monitor the amount and type of drugs taken through
urine and blood analysis. Tests can determine the presence of the prescribed
drugs as well as others, such as tranquilizers or street drugs, which may have
been taken. It is more difficult to verify that a psychosocial treatment has
been delivered as intended, but some helpful methods of verifying this have
been recently developed (e.g., audio or videotaping therapy sessions, and
having them blindly evaluated by a skilled clinician).
A final requirement is that the number of patients be large enough, and
appropriate methods of statistical analysis be chosen, to permit valid proba-
bility statements about the meaning of the findings.
If a treatment method is reasonably promising and interesting, a report of
a controlled treatment trial with most of the above features will find accep-
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tance for publication in one of the leading journals, regardless of what the
results show.
If one well-designed trial, as described above, shows a treatment to be
substantially superior to another, or if several less rigorous investigations
agree in finding it effective, the scientific community will begin to regard the
treatment as probably effective.
Established Effectiveness
If several well-designed, controlled studies agree in showing one form of
treatment to be substantially superior to another, the scientific community
will usually consider the effectiveness of the treatment to be established. If
there are other treatments that are also effective for the condition, additional
research will be necessary to determine the appropriate conditions under
which each should be used. If different, well-designed treatment trials give
different results, additional research, including a careful examination of
possible reasons for the disagreement, will be necessary before a final
conclusion about effectiveness can be reached.
Application in Practice
Unfortunately it is not possible to conduct a clinical practice only with
methods established as effective. At the moment, the number of such treat-
ments is limited, and not one is effective for every patient or client. Respon-
sible practitioners are expected to know where various treatment plans stand
in the research scheme and any limitations on their effectiveness. They also
have an obligation to disclose this information fully to their patients or clients.
CONCLUSION
From time to time, someone claims astounding results that no one else is
good enough or smart enough to duplicate. Most of these claimants are either
naive enthusiasts or outright frauds. Some warning signs:
1. The complaint that they are being ignored or excluded by the &dquo;establishment&dquo;
or its equivalent;
2. Portrayal of the &dquo;establishment&dquo; (or equivalent) as too set in its ways to accept
anything new, or as protecting its self-interest against new ideas;
3. Claims that cures are complete or surefire;
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4. Words and phrases such as &dquo;amazing,&dquo; &dquo;never-dreamed-of,&dquo; &dquo;unique,&dquo; or
&dquo;special&dquo;;
5. Belittlement of other approaches;
6. Vagueness about methods.
However, in science nothing is ever taken as an established fact until there
exists a published set of instructions (in effect, a &dquo;cookbook&dquo;) for replicating
results and until the scientific community is convinced that any competent
investigator can get the same results by following those written instructions.
As Winston Churchill said of democracy, &dquo;This appears to be the worst
possible system, except for all the others.&dquo;
